Latoya Buford
Family · Austell, GANPI 1043738909
Payments from drug & device makers
Across 96 payments — averaging $25.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$893
- Novo Nordisk$479
- Lilly USA, LLC$372
- Collegium Pharmaceutical, Inc.$145
- Antares Pharma, Inc.$90
- Eisai Inc.$71
- plus $393 from 14 others
What the payments were for
- Food & beverage$2,443100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $893 |
| Novo Nordisk | 24 | $479 |
| Lilly USA, LLC | 16 | $372 |
| Collegium Pharmaceutical, Inc. | 7 | $145 |
| Antares Pharma, Inc. | 5 | $90 |
| Eisai Inc. | 4 | $71 |
| Boehringer Ingelheim | 3 | $55 |
| GSK | 3 | $42 |
| Amgen | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Exact Sciences | 2 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| AbbVie | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Protega Pharmaceutials Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,443 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $44,637 |
| MounjaroTirzepatide | 23 | $27,859 |
| FarxigaDapagliflozin Propanediol | 16 | $19,333 |
| JardianceEmpagliflozin | 12 | $18,986 |
| TrulicityDulaglutide | 13 | $14,186 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 41 | $10,412 |
| Gabapentin | 109 | $1,708 |
| Atorvastatin Calcium | 181 | $1,297 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,007 |
| Levothyroxine Sodium | 61 | $652 |
| Amlodipine Besylate | 136 | $575 |
| Fluticasone Propionate | 35 | $526 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 41 | $490 |
| Pregabalin | 38 | $473 |
| Buprenorphine Hcl | 15 | $443 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $479 | $44,63733 claims |
| Lilly USA, LLCMounjaro, Trulicity | $372 | $42,04536 claims |
| AstraZenecaFarxiga | $893 | $19,33316 claims |
| Boehringer IngelheimJardiance | $55 | $18,98612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.
Other family in Austell
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.